Novonesis (Novozymes) B (NSISBC.XD)
DKK 410.0
(-0.89%)
DKK 410.0
(-0.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.74 Billion DKK | 16.08% |
| 2022 | 4.95 Billion DKK | 6.91% |
| 2021 | 4.63 Billion DKK | 8.2% |
| 2020 | 4.27 Billion DKK | 2.08% |
| 2019 | 4.19 Billion DKK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.35 Billion DKK | 54.06% |
| 2024 Q2 | 2.35 Billion DKK | -0.01% |
| 2023 Q2 | 1.5 Billion DKK | 4.38% |
| 2023 Q4 | 1.53 Billion DKK | 21.33% |
| 2023 Q1 | 1.43 Billion DKK | 7.4% |
| 2023 FY | 5.73 Billion DKK | 15.76% |
| 2023 Q3 | 1.26 Billion DKK | -15.93% |
| 2022 Q3 | 950 Million DKK | 0.0% |
| 2022 FY | 4.95 Billion DKK | 6.91% |
| 2022 Q4 | 1.33 Billion DKK | 40.84% |
| 2021 FY | 4.63 Billion DKK | 8.2% |
| 2020 FY | 4.27 Billion DKK | 2.08% |
| 2019 FY | 4.19 Billion DKK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|